This study reexamined the mechanisms
for oxidative organic degradation
by the binary mixture of periodate and H2O2 (PI/H2O2) that was recently identified as a new advanced
oxidation process. Our findings conflicted with the previous claims
that (i) hydroxyl radical (•OH) and singlet oxygen
(1O2) contributed as the primary oxidants, and
(ii) •OH production resulted from H2O2 reduction by superoxide radical anion (O2
•–). PI/H2O2 exhibited
substantial oxidizing capacity at pH < 5, decomposing organics
predominantly by •OH. The likelihood of a switch
in the major oxidant under varying pH conditions was revealed. IO4
– as the major PI form under acidic conditions
underwent one-electron reduction by H2O2 to
yield radical intermediates, whereas H2I2O10
4– preferentially occurring at pH >
7 caused 1O2 generation through two-electron
oxidation of
H2O2. PI reduction by O2
•– was suggested to be a key reaction in •OH production,
on the basis of the electron paramagnetic resonance detection of methyl
radicals in the dimethyl sulfoxide solutions containing PI and KO2, and the absence of deuterated and 18O-labeled
hydroxylated intermediates during PI activation using D2O and H2
18O2. Finally, simple oxyanion
mixing subsequent to electrochemical PI and H2O2 production achieved organic oxidation, enabling a potential strategy
to minimize the use of chemicals.
Studies suggest that time-restricted feeding (TRF) may prevent obesity and its commodities. At present, little is known about how TRF impacts immune cells, and whether such an effect is linked to altered metabolic parameters under condition of a high-fat diet (HFD)-induced obesity. To address these issues, we conducted a study in which we determined whether TRF has therapeutic efficacy against weight gain, adiposity, as well as associated immune cell disturbance found in obese mice. Six-week-old male C57BL/6 mice were fed a low-fat diet (LFD) or HFD ad libitum for six weeks, after which time a subgroup of HFD mice was switched to the 10 h TRF paradigm (HFD-TRF) for additional eight weeks. We found that TRF intervention reduced HFD-induced weight gain. Even with comparable fat mass and mean adipocyte area, the HFD-TRF group had lower mRNA levels of proinflammatory cytokine Tnfα and chemokine Ccl8, along with reduced numbers of adipose tissue macrophages (ATM), CD11c+ ATM, and CD8+ T cell compared to the HFD group, while maintaining CD8+ to CD4+ ratio at levels similar to those in the LFD group. Furthermore, TRF intervention was effective in improving glucose tolerance and reducing HOMA-IR. Taken together, our findings suggest that TRF restores the obesity-induced alteration in immune cell composition, and this effect may in part contribute to health benefits (including insulin sensitivity) of practicing TRF.
This paper presents our investigation and experimental validation of a thermally reconfigurable shape memory alloy (SMA)-based metamaterial with the offered degree of freedom of SMA mechanical features. The metamaterial unit cell consists of a two-way helical SMA acting as the resonator element and a cartridge heater for controlling the excitation temperature of the helical SMA. Experimental results of electrical control of the cartridge heater's excitation temperature show that as the temperature increases from room temperature (25°C) to approximately 92°C-corresponding to input DC voltages of 0 and 4 V, respectivelythe metamaterial structure acts as a switchable absorber with an absorptivity of 97.2% and a reflector with a reflectivity of 89.4% at 7.13 GHz. Additionally, it deforms to its initial state as the temperature decreases to room temperature.
N‐Benzoyl‐L‐threonine‐isopropyl‐ester‐mediated crystallization‐induced dynamic resolution (CIDR) of configurationally labile α‐bromo arylacetates has been investigated. The CIDR was successfully used for the asymmetric preparation of these compounds with up to 98:2 dr, under solution and solvent‐free conditions. Subsequent nucleophilic substitution reactions with sulfur and oxygen nulceophiles gave α‐thio and α‐oxy arylacetates with up to 98:2 dr. The method was further developed for the preparation of highly enantioenriched 2‐phenylthio‐2‐arylethanols with up to 97:3 er, and 1,4‐benzoxazin‐3‐ones with up to 94:6 er.
Glucose-monitoring sensors are necessary and have been extensively studied to prevent and control health problems caused by diabetes. Spoof localized surface plasmon (LSP) resonance sensors have been investigated for chemical sensing and biosensing. A spoof LSP has similar characteristics to an LSP in the microwave or terahertz frequency range but with certain advantages, such as a high-quality factor and improved sensitivity. In general, microwave spoof LSP resonator-based glucose sensors have been studied. In this study, a millimeter-wave-based spoof surface plasmonic resonator sensor is designed to measure glucose concentrations. The millimeter-wave-based sensor has a smaller chip size and higher sensitivity than microwave-frequency sensors. Therefore, the microfluidic channel was designed to be reusable and able to operate with a small sample volume. For alignment, a polydimethylsiloxane channel was simultaneously fabricated using a multilayer bonding film to attach the upper side of the pattern, which is concentrated in the electromagnetic field. This real-time sensor detects the glucose concentration via changes in the S11 parameter and operates at 28 GHz with an average sensitivity of 0.015669 dB/(mg/dL) within the 0–300 mg/dL range. The minimum detectable concentration and the distinguishable signal are 1 mg/dL and 0.015669 dB, respectively, from a 3.4 μL sample. The reusability and reproducibility were assessed through replicates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.